SCHEMBL22839944

SCHEMBL22839944

CNc1c(O)ccc(CCN(Cc2ccc(C=O)c(C#N)c2)C(=O)OC(C)(C)C)c1/C=C\C=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22839937 0.82 NAMPT (0.33) NAMPT
SCHEMBL22839961 0.82 NAMPT (0.33) NAMPT
SCHEMBL22839824 0.81 HDAC1 (0.39) NAMPT
SCHEMBL22839935 0.81 PPARG (0.36) NAMPT
SCHEMBL22839877 0.80 NAMPT (0.38) NAMPT
SCHEMBL22839951 0.79 NAMPT (0.31) NAMPT
SCHEMBL22839942 0.77 EPHX2 (0.33) —
SCHEMBL22839818 0.77 EPHX2 (0.34) —
SCHEMBL22839880 0.76 — —
SCHEMBL22839893 0.76 SSTR4 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 — — EP disclosed
Send feedback